Pharmaxis
Home
News
Media Releases
Media 2010

Media Releases

MEDIA RELEASES

20.12.2010 - Bronchitol EU Marketing Authorisation Update
16.12.2010 - Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial
15.12.2010 - Pharmaxis Holds Pre-NDA Meeting with FDA for Bronchitol
13.12.2010 - Bronchitol Recommended for Approval by Australian Advisory Committee
07.12.2010 - Phase II Trial of ASM8 in Asthma Commences
22.10.2010 - Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
20.10.2010 - Chairman's Address to Annual General Meeting
20.10.2010 - Pharmaxis Chief Executive Officer Resumes Office
14.10.2010 - Recording of Investor Conference Call - 14 October 2010
13.10.2010 - Quarterly Report to Shareholders September 2010
12.10.2010 - Conference Call Details - September 2010 Quarterly Report to Shareholders
06.10.2010 - US Food and Drug Administration Approves Aridol
31.08.2010 - Agreement for European Marketing of Bronchitol
22.07.2010 - Recording of Investor Conference Call - 22 July 2010
20.07.2010 - Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call
08.07.2010 - Update on Pharmaxis CEO
23.06.2010 - Recording of Investor Conference Call - 22 June 2010
22.06.2010 - Investor Conference Call - Clinical Trial Results
22.06.2010 - Pharmaxis Announces Results for Second Phase III Trial of Bronchitol in Cystic Fibrosis
18.06.2010 - Pharmaxis CEO
17.05.2010 - Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment
27.04.2010 - Pharmaxis provides FDA resubmission for Aridol US marketing application
15.04.2010 - Recording of Investor Conference Call - 15 April 2010
14.04.2010 - Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis
12.04.2010 - Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call
11.03.2010 - Pharmaxis Completes Phase II clinical study with ASM8 in asthma patients
09.02.2010 - Pharmaxis completes clinical trial with the antifibrotic agent, PXS25
09.02.2010 - Pharmaxis completes acquisition of Canadian company Topigen Pharmaceuticals Inc
28.01.2010 - Recording of Investor Conference Call - 28 January 2010
22.01.2010 - Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call
12.01.2010 - Pharmaxis to acquire Canadian company TOPIGEN Pharmaceuticals Inc.

Category:

Media Releases

MEDIA RELEASES

PAGE CONTENTS